C
PNT

Covestor’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Covestor’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13
Closed – – 2872
2023
Q3 		$0 Buy
+13
New +$108 ﹤0.01% 2868

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Covestor's PNT Position: Q4 2023 in Review

Covestor sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 13 shares.

Covestor first reported a position in PNT in Q3 2023 and held it in 1 quarter. The position peaked at $0 in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Covestor reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Covestor sold 13 POINT Biopharma Global Inc. Common Stock shares in Q4 2023.
  • Covestor first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Covestor's POINT Biopharma Global Inc. Common Stock position peaked at $0 in Q3 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Covestor's 13F filing for Q4 2023, filed 9 Feb 2024.